Darlene Noci
Corporate Officer/Principal presso NUVALENT, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
Darlene Noci is the founder of Noci Strategic Consulting LLC, which was founded in 2018.
Currently, Ms. Noci is the Chief Development Officer at Nuvalent, Inc. since 2022.
Previously, Ms. Noci held the position of Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc. Ms. Noci also served as the VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and as a Principal at EMD Serono, Inc. from 2014 to 2016.
Ms. Noci obtained a graduate degree from Harvard University and an undergraduate degree from Adelphi University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0.06% | 22/03/2024 | 33 300 ( 0.06% ) | 2 M $ | 31/05/2024 |
Posizioni attive di Darlene Noci
| Società | Posizione | Inizio |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20/07/2022 |
Precedenti posizioni note di Darlene Noci
| Società | Posizione | Fine |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Consigliere Generale | 01/05/2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2016 |
| Noci Strategic Consulting LLC | Fondatore | - |
| AVEO PHARMACEUTICALS, INC. | Consigliere Generale | - |
Formazione di Darlene Noci
| Harvard University | Graduate Degree |
| Adelphi University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Nuvalent, Inc. | |
| Noci Strategic Consulting LLC |
- Borsa valori
- Insiders
- Darlene Noci
